Cost-effectiveness of interferon for high-risk (stage III) melanoma patients
Guillem, V., Alvarez-Mon, M., Camacho, F., Diaz-Perez, J.L., Diaz-Rubio, E., Gonzalez-Larriba, J.L., Lopez-Lopez, J.J., Moreno, J.A., Serrano, S., Toribio, J.Volume:
35
Langue:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(99)81927-3
Date:
September, 1999
Fichier:
PDF, 159 KB
english, 1999